Hantz Financial Services’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Hantz Financial Services’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	350	–	–	﹤0.01%	2637
2025 Q4	$0	Buy	+350	New	–	﹤0.01%	2563
2025 Q3	–	Sell	-350	Closed	–	–	2475
2025 Q2	$0	Hold	350	–	–	﹤0.01%	2328
2025 Q1	$0	Buy	+350	New	–	﹤0.01%	2023
2024 Q4	–	Sell	-350	Closed	–	–	1243
2024 Q3	$0	Buy	+350	New	–	﹤0.01%	1221
2024 Q2	–	Sell	-350	Closed	–	–	1327
2024 Q1	$0	Buy	+350	New	–	﹤0.01%	1328

Hantz Financial Services's KLDO Position: Q1 2026 in Review

Hantz Financial Services held its Kaleido Biosciences, Inc. Common Stock (KLDO) position steady in Q1 2026 at 350 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

Hantz Financial Services first reported a position in KLDO in Q1 2024 and has held it in 6 quarters since. 3 funds tracked by Wall St. Rank hold KLDO as of Q1 2026.

Hantz Financial Services held 350 shares of Kaleido Biosciences, Inc. Common Stock worth $0 as of Q1 2026.
Hantz Financial Services left its Kaleido Biosciences, Inc. Common Stock share count unchanged in Q1 2026.
Kaleido Biosciences, Inc. Common Stock made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #2637 holding.
Hantz Financial Services first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2024 and has held it in 6 quarters since.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.